JAMP PIRFENIDONE
Identification of Jamp Pirfenidone
No description |
Google image searchProduct monograph
Active ingredient
pirfenidone, 267 MG
DIN: 02509938
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 04-JUN-2021
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AX — Other immunosuppressants (ATC, ATC/DDD)
- L04AX05 — PIRFENIDONE (ATC/DDD)
Reference brand drug: Esbriet
Pharmaceutical standard: MFR